Mwandishi:
Mhariri:
ULY CLINIC
Dkt. Benjamin L, MD
16 Machi 2021 16:22:52
Meclizine na ujauzito
Meclizine ni piperazine aina ya antihistamine inayotumika sana kama dawa kichefuchefu na kutapika. Kwa ujumla dawa jamii ya antihistamine huchukuliwa kuwa na hatari kidogo za kusababisha madhara ya kiuumbaji kwa kichanga, hata hivyo, matumizi karibia na kujifungua kabla ya muda kufika huongeza hatari ya vichanga kuzaliwa na tatizo la kiuumbaji la fibroplasia ya retrolental
Ushauri dhidi ya matumizi kwa mama mjamzito
Inapatana na ujauzito
Inapatana na ujauzito ina maana gani?
Uzoefu wa matumizi kwa binadamu kuhusu dawa hii au dawa zingine zilizo kundi moja au zenye kufanya kazi kwa utaratibu unaofanana, zinatosha kuonyesha kuwa, madhara kwa kichanga tumboni ni madogo sana au hakuna kabisa. Tafiti za uzazi kwa wanyama hazina uhalisia kwa binadamu.
Ushauri wa matumizi kwa mama anayenyonyesha
Hakuna (chache) taarifa za binadamu- Inawezekana patana na unyonyeshaji
Hakuna (chache) taarifa za binadamu- Inawezekana patana na unyonyeshaji, ina maana gani?
Hakuna taarifa za uzoefu kuhusu matumizi ya dawa hii kwa mama anayenyonyesha au kuna taarifa chache. Taarifa chache zilizopo zinaonyesha kuwa dawa hii haiwasilishi hatari yenye mashiko kwa kichanga anayenyonya maziwa ya mama anayetumia dawa.
ONYO: Usitumie dawa yoyote bila ushauri wa daktari. Dawa zinaweza kuleta madhara mwilini na pia matumizi ya baadhi ya dawa pasipo ushauri na vipimo husababisha vimelea kuwa sugu dhidi ya dawa hiyo.
ULY clinic inakushauri kuwasiliana na daktari wako unapotaka kuchukua maamuzi yoyote yanayohusu afya yako.
Wasiliana na daktari/Mfamasia wa ULY clinic kwa ushauri na Tiba au kuandikiwa dawa kwa kupiga simu au Kubonyeza Pata tiba chini ya tovuti hii.
Imeboreshwa,
1 Julai 2023 17:21:36
Rejea za mada hii
1. Product information. Antivert. Pfizer, 2000.
2. Watson GI. Meclozine (“Ancoloxin”) and foetal abnormalities. Br Med J 1962;2:1446.
3. Smithells RW. “Ancoloxin” and foetal abnormalities. Br Med J 1962;2:1539.
4. Diggorg PLC, Tomkinson JS. Meclozine and foetal abnormalities. Lancet 1962;2:1222.
5. Carter MP, Wilson FW. “Ancoloxin” and foetal abnormalities. Br Med J 1962;2:1609.
6. Macleod M. “Ancoloxin” and foetal abnormalities. Br Med J 1962;2:1609.
7. Lask S. “Ancoloxin” and foetal abnormalities. Br Med J 1962;2:1609.
8. Leck IM. “Ancoloxin” and foetal abnormalities. Br Med J 1962;2:1610.
9. McBride WG. Drugs and foetal abnormalities. Br Med J 1962;2:1681.
10. Fagg CG. “Ancoloxin” and foetal abnormalities. Br Med J 1962;2:1681.
11. Barwell TE. “Ancoloxin” and foetal abnormalities. Br Med J 1962;2:1681–2.
12. Woodall J. “Ancoloxin” and foetal abnormalities. Br Med J 1962;2:1682.
13. McBride WG. Drugs and congenital abnormalities. Lancet 1962;2:1332.
14. Lenz W. Drugs and congenital abnormalities. Lancet 1962;2:1332–3.
15. David A, Goodspeed AH. “Ancoloxin” and foetal abnormalities. Br Med J 1963;1:121.
16. Gallagher C. “Ancoloxin” and foetal abnormalities. Br Med J 1963;1:121–2.
17. Watson GI. “Ancoloxin” and foetal abnormalities. Br Med J 1963;1:122.
18. Mellin GW, Katzenstein M. Meclozine and foetal abnormalities. Lancet 1963;1:222–3.
19. Salzmann KD. “Ancoloxin” and foetal abnormalities. Br Med J 1963;1:471.
20. Burry AF. Meclozine and foetal abnormalities. Br Med J 1963;1:1476.
21. Smithells RW, Chinn ER. Meclozine and foetal abnormalities. Br Med J 1963;1:1678.
22. O’Leary JL, O’Leary JA. Nonthalidomide ectromelia. Report of a case. Obstet Gynecol 1964;23:17–20.
23. Smithells RW, Chinn ER. Meclozine and foetal malformations: a prospective study. Br Med J 1964;1:217–8.
24. Pettersson F. Meclozine and congenital malformations. Lancet 1964;1:675.
25. Yerushalmy J, Milkovich L. Evaluation of the teratogenic effect of meclizine in man. Am J Obstet Gynecol 1965;93:553–62.
26. Sadusk JF Jr, Palmisano PA. Teratogenic effect of meclizine, cyclizine, and chlorcyclizine. JAMA 1965;194:987–9.
27. Lenz W. Malformations caused by drugs in pregnancy. Am J Dis Child 1966;112:99–106.
28. Lenz W. How can the teratogenic action of a factor be established in man? South Med J 1971;64(Suppl1):41–7.
29. Heinonen OP, et al. Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group, 1977.
30. Milkovich L, Van den Berg BJ. An evaluation of the teratogenicity of certain antinauseant drugs. Am J Obstet Gynecol 1976;125:244–8.
31. Nelson MM, Forfar JO. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J 1971;1:523–7.
32. Shapiro S, Kaufman DW, Rosenberg L, Slone D, Monson RR, Siskind V, Heinonen OP. Meclizine in pregnancy in relation to congenital malformations. Br Med J 1978;1:483.
33. Anonymous. Pink Sheets. Meclizine, cyclizine not teratogenic. FDC Rep 1974;2.